| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |